The impact of 2DG on glycolysis inhibition resulted in reduced activation of the EM and TEMRA CD8 T cell subsets of patients with RRMS, which showed lower expression of the early activation marker CD69 and the high-affinity IL-2 receptor CD25 and lower TNF α production (Figure 4G). This evidence concerns the gene TNF and relapsing-remitting multiple sclerosis.